The largest database of trusted experimental protocols

Mcd45.2 apc 104

Manufactured by BioLegend
Sourced in United States

MCD45.2-APC (104) is a fluorescently labeled antibody that binds to the CD45 antigen. CD45 is a transmembrane protein tyrosine phosphatase expressed on the surface of all nucleated hematopoietic cells. The MCD45.2-APC (104) antibody is conjugated to the fluorescent dye allophycocyanin (APC).

Automatically generated - may contain errors

2 protocols using mcd45.2 apc 104

1

Jurkat and BW5147 Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Jurkat E6.1 cells and the mouse thymoma cell line BW5147 were derived from in-house stocks and cultured as previously described [52 (link)]. All cell lines were cultured in RPMI 1640 supplemented with 10% FBS, penicillin (100 U/mL), and streptomycin (100 μg/mL) (all from Sigma Aldrich, St. Louis, MO, USA). Cell lines were tested for mycoplasma contamination using a previously described reporter system [53 (link)]. The generation of the Jurkat NFκB-eGFP cell line and the T cell stimulator cell line (TCS) has been described previously [34 (link),35 (link)]. The T cell stimulator cell line expresses a membrane-bound human CD3 antibody single-chain fragment, which can activate T cells by engaging their CD3/TCR complex [35 (link)]. To assess the surface expression of the receptors, the following antibodies were purchased from Biolegend (San Diego, CA, USA): HVEM-PE (122), BTLA-APC (MIH26), CD14-APC (63D3), and mCD45.2-APC (104). Flow cytometry analysis was performed on a FACSCalibur™ flow cytometer (BD Bioscience, Franklin Lakes, NJ, USA). FlowJo software (version 10.6.1, Tree Star, Ashland, OR, USA) was used for flow cytometry data analysis.
+ Open protocol
+ Expand
2

Cell Line Authentication and Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
In this study cell lines were cultured in RPMI1640 at 37°C and 5% CO2. Staining of the cell lines with a panel of antibodies provided authentication. Mycoplasma testing was performed for all cell lines using an THP-1 reporter assay developed in our lab.52 (link) For surface expression of mICOS constructs a h/mICOS-APC (C398.4A, Biolegend, San Diego, CA) antibody was used. αCD19 construct expression was validated with a biotinylated Strep-tag II mAb (GenScript, NJ) followed by Streptavidin-PE staining (BD Pharmingen, San Diego, CA). Membrane bound αCD3 expression on TCS was detected with a DyLight-649-labeled goat-anti-mouse IgG (H+L) antibody (Jackson ImmunoResearch, West Grove, PA). mICOS-L and CD19 expression were verified using mICOS-L-PE (HK5.3) and CD19-APC (HIB19) from Biolegend. For TCS exclusion in reporter assays a mCD45.2-APC (104) from Biolegend was used. LSRFortessa™ or FACSCalibur™ (BD Bioscience, Franklin Lakes, NJ) flow cytometers were used for analysis, followed by a data analysis on the FlowJo software (Tree Star, Ashland, OR).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!